Vanguard Group Inc ARRIVENT BIOPHARMA INC Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025
Number of Shares
1,483,540
Previous 1,503,358 1.32%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
N/A
-19,818 Reduced 1.32%
1,483,540 $0
Q1 2025

May 09, 2025
BUY
N/A
86,067 Added 6.07%
1,503,358 $0
Q4 2024

Feb 11, 2025
BUY
N/A
71,741 Added 5.33%
1,417,291 $0
Q3 2024

Nov 13, 2024
BUY
N/A
694,476 Added 106.67%
1,345,550 $0
Q2 2024

Aug 13, 2024
BUY
N/A
2,339 Added 0.36%
651,074 $0
Q1 2024

May 10, 2024
BUY
N/A
648,735 New
648,735 $0
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email